No Data
No Data
Front market [stocks that have moved, stocks that have been created]
*Reso Education <4714> 271 +22 announced the completion of payment of new shares through third-party allotment. *KOKUSAI <6525> 4360 +285 Nomura Securities upgraded investment decisions. *Miura Kogyo <6005> 3020 +176.5 is it a strong buying advantage from the current favorable financial results evaluation? *Kyushu FG<7180> 1046 +60.5 The regional bank is high due to rising long-term interest rates. *Evaluation of the SOMPO <8630> 3346 +173 medium-term plan will increase further. *Iyogi
Nikkei Average Contribution Ranking (advance closing) ~ The Nikkei Average continued to decline slightly, and Fast Rite was pushed down by about 35 yen per brand
The number of gains and falls of the Nikkei Average constituent stocks as of closing 29 days ago was 76 stocks with price increases, 148 stocks with price drops, and 1 stock unchanged. The Nikkei Average continued to decline slightly. The forward market transaction was closed at 38789.52 yen (estimated turnover of 920 million shares), which was 65.85 yen lower (-0.17%) compared to the previous day. The US stock market was mixed on the 28th. The Dow average depreciated by $216.73 (-0.55%) to $38852.86, and the Nasdaq rose 99.09 points (+ 0.59%) to 17019
3 points to pay attention to in the aftermath - developments where interest rate increases are heavy but financial stocks can be bought
I would like to pay attention to the following 3 points in the late-day transaction on the 29th. ・The Nikkei Average continues to fall slightly, and interest rate rises are heavy, but financial stocks are being bought · The dollar and yen are sluggish, and yen can be bought due to high interest rates · First Rate <9983>, and Daikin <6367>■The Nikkei Average continues to decline slightly, interest rate rises are heavy, but financial stocks are being bought The Nikkei Average continues to fall slightly. Prior to 38789.52 yen (estimated turnover of 920 million shares), which was 65.85 yen lower (-0.17%) than the previous day
INPEX, petroleum resources, etc. (additional) Rating
Upgrade-Bullish Code | Stock Name | Securities Company | Conventional | After Change |------|--------------|--------------|--------------|<4911>|Shiseido | Yamato | “4” | “3” |<6525>|KOKUSAI | Nomura | “Neutral”
The Nikkei Average continues to decline slightly, and interest rate increases are heavy, but financial stocks are being bought
The Nikkei Average continued to decline slightly. The forward market transaction was closed at 38789.52 yen (estimated turnover of 920 million shares), which was 65.85 yen lower (-0.17%) compared to the previous day. The US stock market was mixed on the 28th. The Dow average closed at 38852.86 dollars with a depreciation of 216.73 dollars (-0.55%), the Nasdaq closed at 17019.88 with a 99.09 point increase (+ 0.59%), and the S&P 500 at 5306.04 with a 1.32 point increase (+ 0.02%). US Federal Reserve Board Member
Notable stock digest (front field): RENOVA, KOKUSAI, Teijin, etc.
Asahi Kasei <3407>: fell by 1030 yen (-20 yen). The acquisition of Caliditas, a Swedish pharmaceutical company, has been announced. All shares have been acquired through TOB, and it seems that the total acquisition amount is expected to be 173.9 billion yen. Cariditas is developing drugs for kidney disease in the United States and elsewhere. On the company side, it seems that they are aiming for sales of 1 trillion yen in the pharmaceutical and medical device business in fiscal year 30. The final profit and loss of Cariditas for the fiscal year ended 23/12 was in deficit of about 6.8 billion yen, but future sales are expected to expand rapidly
No Data